Chromic-P32 phosphate treatment of implanted pancreatic carcinoma: Mechanism involved

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

271

HTML

1884

Figures (1-5)

202

Tables (1-3)

162

Sum=2519

Apr 14, 2005 (publication date) through May 6, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Apr 14, 2005; 11(14): 2101-2108
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2101

Full Size Figure Download Figure

Figure 1 Effective half-life in ³²P colloids 7. 4 and 14.8 MBq injected group averaged 13 d.

Citation: Liu L, Feng GS, Gao H, Tong GS, Wang Y, Gao W, Huang Y, Li C. Chromic-P32 phosphate treatment of implanted pancreatic carcinoma: Mechanism involved. World J Gastroenterol 2005; 11(14): 2101-2108
URL: https://www.wjgnet.com/1007-9327/full/v11/i14/2101.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i14.2101